CareDx is a global transplant diagnostics company with product offerings of the pre- and post-transplant continuum. It focuses on the discovery, development, and commercialization of clinically differentiated diagnostic surveillance solutions for transplant patients. It offers the AlloMap, a gene expression testing service that helps clinicians monitor and identify heart transplant recipients with stable graft function who have a low probability of moderate-to-severe acute cellular rejection.